(6R,9S)-6″-(4″-hydroxybenzoyl)-roseoside, a new megastigmane derivative from Ouratea polyantha and its effect on hepatic glucose-6- phosphatase

Natural Product Communications

Volumn 7, Issue 8, 2012, Pages 973-976

  Bermúdez, Jairo ^a,b   Rodríguez, María ^a   Hasegawa, Masahisa ^a   González Mujica, Freddy ^c   Duque, Sandra ^c   Ito, Yoichiro ^b  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

Author keywords

(6R,9S) 6 (4 Hydroxybenzoyl) roseoside; Agathisflavone; Countercurrent chromatography; Glucose 6 phosphatase; Megastigmanes; Ouratea polyantha; Terpenes

Indexed keywords

4 HYDROXYBENZOIC ACID; 6'' (4'' HYDROXYBENZOYL)ROSEOSIDE; BIFLAVONEAGATHISFLAVONE; GLUCOSE 6 PHOSPHATASE; OURATEA POLYANTHA EXTRACT; PLANT EXTRACT; TERPENE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; COLUMN CHROMATOGRAPHY; COUNTER CURRENT CHROMATOGRAPHY; DRUG STRUCTURE; ENZYME INHIBITION; HETERONUCLEAR MULTIPLE BOND CORRELATION; HETERONUCLEAR MULTIPLE QUANTUM COHERENCE; LIVER MICROSOME; MALE; MASS SPECTROMETRY; NONHUMAN; NUCLEAR OVERHAUSER EFFECT; OCHNACEAE; OURATEA POLYANTHA; PLANT LEAF; PLANT STEM; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 84865286771     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x1200700802     Document Type: Article

References (25)

1. WHO: World Health Organization (2004).
2. Kuo-Chen C. (2004)Molecular therapeutic target for type-2 diabetes, Journal of Proteome Research, 3, 1284-1288.
3. Rodríguez M, Hasegawa M, González-Mujica F, Motta N, Castillo A, Castillo J, Zea E, Mora K, Sousa L, González A, Camejo D. (2008) Antidiabetic and antiradical activities of plants from Venezuelan Amazon. Revista Brasileira de Farmacognosia, 18, 331-338.
4. Jiménez J, Hasegawa M, Rodríguez M, Estrada O, Méndez J, Castillo A, González-Mujica F, Motta N, Romero Vecchione W. (2001) Biological screening of plants of the Venezuelan Amazons. Journal of Ethnopharmacology, 77, 77-83.
5. Watson L. Dallwitz MJ. (1992) The families of flowering plants (available on http://biodiversity.uno.edu.delta).
6. Velandia J, Carvalho M, Braz-Filho R. (1998) Novel trichloro- and tetrachloroisoflavones isolated from Ouratea semiserrata. Natural Product Research,12, 191-198.
7. Ramos L. (2007) Considerações sobre oe gêneros Ouratea e Luxemburgia, estudo químico de duas espécies de ochnaceae: Ouratea hexasperma St Hil e Ouratea cuspidata St. Hil e actividades biologicas. Doctoral Thesis, Universidade Federal Rural do Rio de Janeiro. (in Portuguese).
8. De Souza J, Fernandes C, Grivicich I, Da Rocha A, De Carvalho M. (2007) Antitumor activity of biflavonoids from Ouratea and Luxemburgia on human cancer cells lines. Indian Journal of Pharmacology, 39, 184-186.
9. Velandia J, De Carvalho M, Braz-Filho R, Werle A. (2002) Biflavonoids and glucopyranoside derivate from Ouratea semiserrata. Phytochemical Analysis, 13, 283-292.
10. Velandia J, Carvalho M, Braz-Filho R. (1998) Ácido ent-16α,17-diidroxicauran-19-óico isolado de Ouratea semiserratae os desafios estereoquímicos dos carbonos quirais C-4 e C-16. Química Nova, 21, 397-404 (in Portuguese).
11. 13C NMR assignments of atranorin and its new acetyl derivative. Journal of Brazilian Chemical Society, 11,143-147.
12. Rodríguez D, Hasegawa M, González-Mújica F. (2007) Biflavona de Ouratea polyantha (Ochnaceae) con actividad inhibitoria sobre la enzima glucosa-6-fosfatasa. Proceedings of IV Encuentro Nacional de Química Medicinal, 18-19 (in Spanish).
13. Burchell A, Waddell ID. (1991) The molecular basis of the hepatic microsomal glucose-6-phosphatase. Biochimica et Biophysica Acta-Molecular Cell Research, 1092, 129-137.
14. McCormack JG, Westergaard N, Kristiansen M, Brand CL, Lau J. (2001) Pharmacological approaches to inhibit endogenous glucose production as a means of anti-diabetic therapy. Current Pharmaceutical Design, 7, 1451-1474.
15. Estrada O, Hasegawa M, González-Mujica F, Motta N, Perdomo E, Solórzano A, Méndez J, Méndez B, Zea E. (2006) Evaluation of flavonoids from Bauhinia megalandra leaves as inhibitor of glucose-6-phosphatase system. Phytotherapy Research, 19, 859-863.
16. Ito Y, Conway W. (1996) High-Speed Countercurrent Chromatography, Wiley-Interscience, New York.
17. Yamano Y, Ito M. (2005) Synthesis of optically active vomifoliol and roseoside stereoisomers. Chemical & Pharmaceutical Bulletin, 55, 541-546.
18. Bahia M, dos Santos J, David JP, David JM. (2005) Biflavonoids and other phenolics from Caesalpinia pyramidalis (Fabaceae). Journal of Brazilian Chemical Society, 16, 1402-1405.
19. A 1 benzodiazepine receptor. Journal of Ethnopharmacology, 103, 2276-2280.
20. Arion WJ, Lange AJ, Walls HE. (1980) Microsomal membrane integrity and the interaction of phlorizin with the glucose-6-phosphatase system. Journal of Biological Chemistry, 255, 10387-10395.
21. Avila L, Hasegawa M, González-Mujica F, Rodríguez M, Tillet S. (2008) Aislamiento de los metabolitos de Bauhinia variegata L., biodirigido por ensayos de inhibición sobre la enzima glucosa-6-fosfatasa. XVII Jornadas Científicas "Dr. Francisco de Venazi", Caracas, Venezuela. (in Spanish).
22. Marcucci O, González-Mujica F, Pérez-Ayuso E. (1983) Alterations of liver nuclear envelopes accompanying thioacetamide administration in rats. Acta Cientifica Venezolana, 34, 109-117.
23. Lowry O, Rosebrough H, Farr A, Randall R. (1951) Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 209-220.
24. Markwell M, Hass S, Bieber L, Tolbert N. (1978) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein sample. Analytical Biochemistry, 87, 206-210.
25. Burchell A, Hume R, Burchell B. (1988) A new microtechnique for the analysis of the human hepatic microsomal glucose-6-phosphatase system. Clinica Chimica Acta, 173, 183-192.